osimertinib
astrazeneca
['adaura', 'lcsm,(-blcsm)', 'aura ,(-laura)']
results of adaura trial at #esmo22 reveal a 5.5-yr disease free survival &amp; reduced recurrence in the brain and spinal cord. #lcsm 
Yale Cancer Center is a collaboration between renowned cancer researchers and physicians @Yale and @SmilowCancer.